Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Cenoté Pharma Ltd., Griffins Court, 24-32 London Road, Newbury, Berkshire, RG14 1JX, UK
Levocarnitine Paediatric 30% Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral solution. Colourless to yellowish, clear solution. |
Levocarnitine 30% w/v (300mg/ml).
Excipients with known effect:
Sorbitol solution (70%) (E420)
Sodium propyl hydroxybenzoate (E217)
Sodium methyl hydroxybenzoate (E219)
Sucrose
Hydrochloric acid, concentrated (for pH-adjustment) (E507)
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| L-carnitine |
Levocarnitine as a factor is necessary in the transport of long-chain fatty acids into the mitochondria-facilitating the oxidation of fatty acids rather than their incorporation into triglycerides. |
| List of Excipients |
|---|
|
Sorbitol solution (70%) (E420) |
Carton box that contains an amber glass bottle with 20ml of drug product, with a plastic polypropylene and low density polyethylene child proof cap and a graduated dosage pipette, along with the patient information leaflet.
Cenoté Pharma Ltd., Griffins Court, 24-32 London Road, Newbury, Berkshire, RG14 1JX, UK
PL 46052/0001
11/01/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
